Allergy Diagnostics Market Is Estimated To Reach $5.7 Billion By 2022

CITY – Northbrook, Country – USA, 2020-Feb-05 — /EPR Network/ —

The global allergy diagnostics market size is expected to reach USD 5.74 billion by 2022 from USD 3.49 billion in 2017, at a CAGR of 10.5%. High incidence and large economic burden of allergic diseases, growing demand for allergy diagnosis, increasing healthcare expenditure, and technological advancements are driving the growth of this market.

Browse 105 market data Tables and 32 Figures spread through 149 Pages and in-depth TOC on “Allergy Diagnostics Market – Global Forecast to 2022”

Request For Sample Insights: https://www.marketsandmarkets.com/requestsampleNew.asp?id=232871701

Globally, the allergy diagnostics market is witnessing growth due to factors such as the high incidence and large economic burden of allergic diseases, rising environmental pollution, increasing healthcare expenditure, and growing access to allergy diagnosis medical insurance in the US.

On the other hand, the lack of awareness of allergic diseases in the developing countries is restraining the growth of this market.

Based on product and service, the allergy diagnostics market is segmented into assay kits, instruments, and services. The instruments segment is further subsegmented into immunoassay analyzers, luminometers, ELISA analyzers, and other instruments. The assay kits segment is expected to grow at the highest CAGR throughout the forecast period. The widespread availability and large consumption of assay kits in allergy testing are expected to drive the growth of this segment in the coming years.

The allergy diagnostics market has been segmented based on test type into in vivo and in vitro tests. In 2017, the in vivo tests segment is expected to account for the largest share of the allergy diagnostics market. The growth of this segment is mainly driven by the increasing adoption of various in vivo tests such as skin prick tests. These tests are dependable, safe, convenient, and cost-effective as compared to the in vitro tests.

Access More About Report: https://www.marketsandmarkets.com/Market-Reports/allergy-diagnostics-market-232871701.html

The allergy diagnostics market has been segmented based on allergens into inhaled allergens, food allergens, drug allergens, and other allergens. In 2017, the inhaled allergens segment is expected to account for the largest share of the allergy diagnostics market. Increasing environmental pollution is one of the major factors driving the growth of this segment.

The key players operating in the allergy diagnostics market include Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd. (Japan), bioMérieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE – Achterrath Laboratorien GmbH (Germany), R-Biopharm AG (Germany), GA Generic Assays GmbH (Germany), Tecan Trading AG (Switzerland), DST Diagnostische Systeme & Technologien GmbH (Germany), ROXALL Medical GmbH (Germany), ALK-Abelló A/S (Denmark), Astra Biotech GmbH (Germany), HAL Allergy Group (Netherlands), Theradiag (France), and Demeditec Diagnostics GmbH (Germany).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. 

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com